Cargando…

Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?

Left ventricular endomyocardial biopsy (EMB) is an essential tool in the management of myocarditis and is conventionally performed via transfemoral access (TFA). Transradial access EMB (TRA-EMB) is a novel alternative and the authors sought to determine its safety and feasibility by conducting a sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyler, Zaccharie, Guttmann, Oliver P, Savvatis, Konstantinos, Jones, Daniel, O’Mahony, Constantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548872/
https://www.ncbi.nlm.nih.gov/pubmed/34733353
http://dx.doi.org/10.15420/icr.2021.20
_version_ 1784590675775324160
author Tyler, Zaccharie
Guttmann, Oliver P
Savvatis, Konstantinos
Jones, Daniel
O’Mahony, Constantinos
author_facet Tyler, Zaccharie
Guttmann, Oliver P
Savvatis, Konstantinos
Jones, Daniel
O’Mahony, Constantinos
author_sort Tyler, Zaccharie
collection PubMed
description Left ventricular endomyocardial biopsy (EMB) is an essential tool in the management of myocarditis and is conventionally performed via transfemoral access (TFA). Transradial access EMB (TRA-EMB) is a novel alternative and the authors sought to determine its safety and feasibility by conducting a systematic review of the literature. Medline was searched in 2020, and cohort demographics, procedural details and complications were extracted from selected studies. Four observational studies with a combined total of 496 procedures were included. TRA-EMB was most frequently performed with a sheathless MP1 guide catheter via the right radial artery. The most common complication was pericardial effusion (up to 11% in one study), but pericardial drainage for tamponade was rare (one reported case). Death and mitral valve damage have not been reported. TRA-EMB was successful in obtaining samples in 99% of reported procedures. The authors concluded that TRA-EMB is a safe and feasible alternative to TFA-EMB and the most common complication is uncomplicated pericardial effusion.
format Online
Article
Text
id pubmed-8548872
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-85488722021-11-02 Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy? Tyler, Zaccharie Guttmann, Oliver P Savvatis, Konstantinos Jones, Daniel O’Mahony, Constantinos Interv Cardiol Structural Left ventricular endomyocardial biopsy (EMB) is an essential tool in the management of myocarditis and is conventionally performed via transfemoral access (TFA). Transradial access EMB (TRA-EMB) is a novel alternative and the authors sought to determine its safety and feasibility by conducting a systematic review of the literature. Medline was searched in 2020, and cohort demographics, procedural details and complications were extracted from selected studies. Four observational studies with a combined total of 496 procedures were included. TRA-EMB was most frequently performed with a sheathless MP1 guide catheter via the right radial artery. The most common complication was pericardial effusion (up to 11% in one study), but pericardial drainage for tamponade was rare (one reported case). Death and mitral valve damage have not been reported. TRA-EMB was successful in obtaining samples in 99% of reported procedures. The authors concluded that TRA-EMB is a safe and feasible alternative to TFA-EMB and the most common complication is uncomplicated pericardial effusion. Radcliffe Cardiology 2021-10-18 /pmc/articles/PMC8548872/ /pubmed/34733353 http://dx.doi.org/10.15420/icr.2021.20 Text en Copyright © 2021, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle Structural
Tyler, Zaccharie
Guttmann, Oliver P
Savvatis, Konstantinos
Jones, Daniel
O’Mahony, Constantinos
Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?
title Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?
title_full Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?
title_fullStr Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?
title_full_unstemmed Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?
title_short Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?
title_sort is this the prime time for transradial access left ventricular endomyocardial biopsy?
topic Structural
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548872/
https://www.ncbi.nlm.nih.gov/pubmed/34733353
http://dx.doi.org/10.15420/icr.2021.20
work_keys_str_mv AT tylerzaccharie isthistheprimetimefortransradialaccessleftventricularendomyocardialbiopsy
AT guttmannoliverp isthistheprimetimefortransradialaccessleftventricularendomyocardialbiopsy
AT savvatiskonstantinos isthistheprimetimefortransradialaccessleftventricularendomyocardialbiopsy
AT jonesdaniel isthistheprimetimefortransradialaccessleftventricularendomyocardialbiopsy
AT omahonyconstantinos isthistheprimetimefortransradialaccessleftventricularendomyocardialbiopsy